Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.
Katelynn Getchell
Advertisement
MedStar Georgetown University Hospital, in Washington, DC
Articles by Katelynn Getchell
Advertisement
Latest Updated Articles
Promising Disease-Modifying Therapies in Parkinson DiseasePublished: April 19th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related related Amyloid Pathology
2
Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni
3
Trofinetide Leads to Real-World Improvements in Rett Syndrome Symptoms, LOTUS Study Finds
4
FDA Delays Review Deadline for Hunter Syndrome Agent Tividenofusp Alfa
5
